We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+6.72%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+466.5%
AUM
$810B
AUM Growth
+$67.4B
Cap. Flow
+$32.8B
Cap. Flow %
4.05%
Top 10 Hldgs %
15.54%
Holding
8,496
New
406
Increased
3,968
Reduced
2,914
Closed
325

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$4.58B
2
MELI icon
Mercado Libre
MELI
+$1.36B
3
DASH icon
DoorDash
DASH
+$1.3B
4
GRAB icon
Grab
GRAB
+$1.22B
5
U icon
Unity
U
+$1.06B

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$2.05B
2
ISRG icon
Intuitive Surgical
ISRG
+$1.36B
3
NVDA icon
NVIDIA
NVDA
+$1.01B
4
DOCU
DocuSign
DOCU
+$992M
5
MSFT icon
Microsoft
MSFT
+$739M

Sector Composition

Rank Sector Weight
1 Technology 20.54%
2 Healthcare 9.55%
3 Financials 9.27%
4 Consumer Discretionary 8.72%
5 Communication Services 7.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMMT icon
4976
Summit Therapeutics
SMMT
$10.8B
$963K ﹤0.01%
358,184
+80,238
+29% +$386K
SDG icon
4977
iShares MSCI Global Sustainable Development Goals ETF
SDG
$172M
$959K ﹤0.01%
10,565
-14,330
-58% -$1.34M
SURE icon
4978
AdvisorShares Insider Advantage ETF
SURE
$57.4M
$958K ﹤0.01%
9,759
-14
-0.1% -$1.36K
SPFF icon
4979
Global X SuperIncome Preferred ETF
SPFF
$141M
$954K ﹤0.01%
81,435
+18,756
+30% +$221K
ESML icon
4980
iShares ESG Aware MSCI USA Small-Cap ETF
ESML
$2.89B
$952K ﹤0.01%
23,620
+20,958
+787% +$849K
MESO
4981
Mesoblast
MESO
$2.03B
$952K ﹤0.01%
99,201
-7,636
-7% -$88.8K
EQC.PRD
4982
DELISTED
Equity Commonwealth 6 1/2% Series D Cumulative Convertible Preferred Shares
EQC.PRD
$951K ﹤0.01%
+31,440
New +$956K
CYB
4983
DELISTED
WisdomTree Chinese Yuan Strategy Fund
CYB
$951K ﹤0.01%
35,633
-65,942
-65% -$1.83M
REVG
4984
DELISTED
REV Group
REVG
$946K ﹤0.01%
66,919
+29,511
+79% +$466K
STRO icon
4985
Sutro Biopharma
STRO
$400M
$946K ﹤0.01%
6,350
+3,736
+143% +$669K
GEF.B icon
4986
Greif Class B
GEF.B
$4.21B
$945K ﹤0.01%
15,807
-15,157
-49% -$975K
AZUL
4987
DELISTED
Azul
AZUL
$944K ﹤0.01%
71,544
-20,828
-23% -$316K
HEAL
4988
Global X Funds Global X HealthTech ETF
HEAL
$29.1M
$944K ﹤0.01%
19,032
-8,530
-31% -$442K
ICVX
4989
DELISTED
Icosavax, Inc. Common Stock
ICVX
$944K ﹤0.01%
41,234
+5,340
+15% +$138K
EELV icon
4990
Invesco S&P Emerging Markets Low Volatility ETF
EELV
$426M
$941K ﹤0.01%
37,974
+11,829
+45% +$295K
VAL icon
4991
Valaris
VAL
$5.36B
$939K ﹤0.01%
26,116
+14,328
+122% +$499K
UWMC icon
4992
UWM Holdings
UWMC
$407M
$938K ﹤0.01%
158,372
-27,169
-15% -$183K
MFD
4993
DELISTED
Macquarie/First Trust Global Infrastructure/Utilities Dividend & Income Fund
MFD
$938K ﹤0.01%
97,246
+846
+0.9% +$8.17K
APRE icon
4994
Aprea Therapeutics
APRE
$7.83M
$936K ﹤0.01%
16,311
+7,063
+76% +$624K
XRLV
4995
DELISTED
Invesco S&P 500 ex-Rate Sensitive Low Volatility ETF
XRLV
$936K ﹤0.01%
17,966
+194
+1% +$9.59K
ALBO
4996
DELISTED
Albireo Pharma Inc
ALBO
$936K ﹤0.01%
40,193
+21,048
+110% +$560K
CURO
4997
DELISTED
CURO Group Holdings Corp.
CURO
$934K ﹤0.01%
58,313
-138,890
-70% -$2.42M
SYRE icon
4998
Spyre Therapeutics
SYRE
$9.12B
$932K ﹤0.01%
7,849
+80
+1% +$12.6K
ABUS icon
4999
Arbutus Biopharma
ABUS
$897M
$930K ﹤0.01%
239,007
+17,823
+8% +$69.2K
DDIV icon
5000
First Trust Exchange-Traded Fund VI First Trust Dorsey Wright Momentum & Dividend ETF
DDIV
$75.1M
$930K ﹤0.01%
27,475
+945
+4% +$31.3K

Similar funds

Morgan Stanley's Q4 2021 Portfolio in Review

As of Q4 2021, Morgan Stanley held 8,496 positions worth $810B, up 9.1% from $742B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Morgan Stanley deployed $32.8B of net new capital in Q4 2021, opening 406 new positions and adding to 3,968 existing holdings. Its largest new stake was Grab: 159,523,860 shares worth $1.14B.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Amazon, an estimated $2.05B trimmed.

  • Morgan Stanley's largest Q4 2021 buy was Grab: 159,523,860 shares worth $1.14B.
  • Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q4 2021, an estimated $4.58B increase.
  • Morgan Stanley's biggest Q4 2021 reduction was Amazon, cutting an estimated $2.05B.
  • Morgan Stanley fully exited Kansas City Southern in Q4 2021, selling an estimated $373M.
  • Morgan Stanley's ten largest holdings make up 16% of its $810B portfolio in Q4 2021.
  • Morgan Stanley opened 406 new positions and closed 325 in Q4 2021.
  • Morgan Stanley's portfolio value rose 9.1% quarter-over-quarter to $810B.

Based on Morgan Stanley's 13F filing for Q4 2021, filed 14 Feb 2022.